Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 1A46 |
Synonyms | |
Therapy Description |
1A46 is a trispecific antibody that targets tumor-expressed CD19 and CD20, and T cell-expressed CD3, which potentially leads to an enhanced cytotoxic T-lymphocyte (CTL) response against tumor cells expressing CD19 and CD20 (NCI Drug Dictionary). |